113 related articles for article (PubMed ID: 10349695)
1. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.
Neary MP; Cort S; Bayliss MS; Ware JE
Semin Liver Dis; 1999; 19 Suppl 1():77-85. PubMed ID: 10349695
[TBL] [Abstract][Full Text] [Related]
2. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
Maddrey WC
Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group.
Ware JE; Bayliss MS; Mannocchia M; Davis GL
Hepatology; 1999 Aug; 30(2):550-5. PubMed ID: 10421667
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
McHutchison JG; Poynard T
Semin Liver Dis; 1999; 19 Suppl 1():57-65. PubMed ID: 10349693
[TBL] [Abstract][Full Text] [Related]
7. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
Bini EJ; Mehandru S
Aliment Pharmacol Ther; 2006 Mar; 23(6):777-85. PubMed ID: 16556180
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
Schvarcz R; Ando Y; Sönnerborg A; Weiland O
J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
[TBL] [Abstract][Full Text] [Related]
9. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C.
Davis GL
Semin Liver Dis; 1999; 19 Suppl 1():49-55. PubMed ID: 10349692
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
[TBL] [Abstract][Full Text] [Related]
14. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
Dieterich DT; Purow JM; Rajapaksa R
Semin Liver Dis; 1999; 19 Suppl 1():87-94. PubMed ID: 10349696
[TBL] [Abstract][Full Text] [Related]
15. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
17. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
18. Use of high-dose interferon in the treatment of chronic hepatitis C.
Shiffman ML
Semin Liver Dis; 1999; 19 Suppl 1():25-33. PubMed ID: 10349690
[TBL] [Abstract][Full Text] [Related]
19. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
20. Re-treatment of chronic hepatitis C with consensus interferon .
Heathcote EJ; Keeffe EB; Lee SS; Feinman SV; Tong MJ; Reddy KR; Albert DG; Witt K; Blatt LM
Hepatology; 1998 Apr; 27(4):1136-43. PubMed ID: 9537455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
